0001127602-21-015894.txt : 20210507
0001127602-21-015894.hdr.sgml : 20210507
20210507164737
ACCESSION NUMBER: 0001127602-21-015894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210506
FILED AS OF DATE: 20210507
DATE AS OF CHANGE: 20210507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POPS RICHARD F
CENTRAL INDEX KEY: 0001126490
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 21903583
MAIL ADDRESS:
STREET 1: 10555 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-05-06
0001520262
Alkermes plc.
ALKS
0001126490
POPS RICHARD F
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
1
Director and CEO, Alkermes plc
Ordinary Shares
2021-05-06
4
M
0
100000
18.105
A
892040
D
Ordinary Shares
2021-05-06
4
S
0
100000
21.7941
D
792040
D
Employee Stock Option (Right to Buy)
18.105
2021-05-06
4
M
0
100000
0
D
2021-05-20
Ordinary Shares
100000
300000
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.54 to $22.16. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
These options are fully vested in accordance with their terms.
/s/ Shantale Greenson, attorney-in-fact for Richard F. Pops
2021-05-07